With over 13 years of experience in health care payment reform and value-based care, Keely leads engagements that assist health care organizations transition to value-based payment and delivery models. Drawing on deep payment policy expertise, she partners with provider organizations to identify and implement strategies for success in alternative payment models (APMs) including shared savings arrangements, capitation and episodic payments. Keely has a passion for leveraging payment reform to improve outcomes, reduce costs and enhance patient experience, and has authored many articles to help advance the movement from volume to value. 

Previously, Keely was a member of the executive leadership team at Archway Health, a value-based care tools and services company that developed the first performance-based stop-loss products for Medicare two-sided risk models. As the SVP of policy and solutions management, Keely led the development of a risk-assessment framework and underwriting capabilities for stop-loss products for Medicare APMs including the Oncology Care Model and Global and Professional Direct Contracting. She was also the company’s liaison with the Centers for Medicare and Medicaid Innovation (CMMI) and led successful advocacy efforts for program improvement. In her prior role as the general manager of bundled payments, she built, managed and grew the Medicare Bundled Payments for Care Improvement (BPCI) and BPCI-Advanced business lines in specialties including cardiology and orthopedics. 

Prior to Archway, Keely led the Government Payment Policy team at Mass General Brigham (formerly Partners HealthCare), the largest health system in New England. She was in charge of Medicare and Medicaid financial forecasting for strategic initiatives and the annual and multiyear budget framework, and she managed the financial analysis of performance-based reimbursement models for the system. Keely also led effective advocacy initiatives with federal and state agencies. 

Keely holds a master of science in health policy and management from the Harvard TH Chan School of Public Health and a bachelor of science in biology from Yale University. Her research at Yale’s Pollard Lab was published in the peer-reviewed journal Molecular Biology of the Cell